✦ LIBER ✦

P1-347 An investigation into the safety, tolerability, and efficacy of high dose rivastigmine treatment in Alzheimer's disease

✍ Scribed by Joshua R. Shua-Haim; Mark D. Pass; Sameer Patel; Paul Lee; Pritesh Patel

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-201: An investigation into the safety,

✍ Joshua Shua-Haim; Dorina Hajnaj; Avraham Tuvy; Syed Zaidi; Paul Lee 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 45 KB

P-202: Combination therapy of rivastigmi

✍ Joshua Shua-Haim; Dorina Hajnaj; Syed Zaidi; Paul Lee; Avraham Tuvy 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 55 KB

P1-377 Safety, tolerability, and caregiv

✍ Joshua R. Shuan-Haim; Mark D. Pass; Suhas Patel; Sameer Patel; Paul Lee; Juanita 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Efficacy and safety of high-dose 13.3mg/

✍ Grossberg, G.; Farlow, M.; Meng, X.; Somogyi, M. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 65 KB

P1-385 A head study of donepezil, rivast

✍ Joshua R. Shua-Haim; Mark D. Pass; Suhas Patel; Sameer Patel; Paul Lee; Pritesh 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 155 KB

P1-337 Safety and tolerability of high d

✍ Mark D. Pass; Joshua R. Shua-Haim; Suhas Patel; Sameer Patel; Paul Lee; Pritesh 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 152 KB